Kalaghazi
KalaGhazi | Corvus Pharmaceuticals Corvus Pharmaceuticals Extends Gains in Premarket Thursday After Reporting 'Strong Progress' in Immune Diseases Treatment
On Wednesday, the company said it will present new data for CPI-818 at the International Conference on Malignant Lymphoma meeting in Lugano, Switzerland from June 13 to 17.
KalaGhazi | ObsEva SA @KalaGhazi
#ObsEva SA has been volatile last week
I do see an upside
Good luck